지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.12
- 수록면
- 757 - 764 (8page)
- DOI
- 10.3947/ic.2022.0123
이용수
초록· 키워드
오류제보하기
Background Nirmatrelvir/ritonavir was Korea's first oral antiviral agent to treat coronavirus disease 2019 (COVID-19). We analyzed the nirmatrelvir/ritonavir prescription rate and treatment outcomes in treatment-eligible patients with COVID-19 receiving home-based care.
Materials and Methods We retrospectively collected data of patients with COVID-19-eligible for nirmatrelvir/ritonavir treatment from January 14, 2022, to February 15, 2022. We analyzed the prescription rate of nirmatrelvir/ritonavir, the reasons for non-prescription, and patient outcomes.
Results A total of 414 patients were included, of whom 44.2% were male, and the mean age was 64.6 (standard deviation [SD] = 8.5). Approximately 73.2% (n = 303) of patients were not prescribed nirmatrelvir/ritonavir. More than fourth-fifths of the patients refused nirmatrelvir/ritonavir treatment (n = 262, 86.5%). The mean symptom duration was significantly shorter in the prescription group (5.2 days [SD = 2.3] vs. 4.4 days [SD = 1.9], P = 0.001). A total of 6 (1.4%) patients were hospitalized, and none of the patients who received nirmatrelvir/ritonavir required admission. Among the patients prescribed nirmatrelvir/ritonavir (n = 111), 17 (15.3%) patients experienced side effects, and 5 (4.5%) patients discontinued nirmatrelvir/ritonavir due to side effects.
Conclusion The nirmatrelvir/ritonavir prescription rate was low, with more than fourth-fifths of non-prescriptions being due to patient refusal. Symptom resolution was faster, and no life-threatening side effects were reported. Accurate information about drug safety must be provided to patients to make informed decisions regarding nirmatrelvir/ritonavir treatment.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
Osong Public Health and Research Persptectives
2024 .04
-
Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding
Journal of Korean Medical Science
2023 .02
-
Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19
Journal of Korean Medical Science
2024 .02
-
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
Kidney Research and Clinical Practice
2022 .11
-
건강보험청구데이터를 이용하여 사용상의 주의사항에 자살이 기재된 약물의 처방 양상 분석
한국임상약학회지
2019 .01
-
Constructing a Real-Time Prescription Drug Monitoring System
Healthcare Informatics Research
2016 .01
-
Drug Prescription Indicators in Outpatient Services in Social Security Organization Facilities in Iran
예방의학회지
2024 .05
-
Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment
Gut and Liver
2021 .01
-
Severe Thrombocytopenia in a Patient with COVID-19
Infection and Chemotherapy
2020 .01
-
Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000?2019
Journal of Korean Medical Science
2021 .09
-
상급종합병원 외래환자의 원내약 처방감사 현황 분석
병원약사회지
2024 .08
-
Prescription of Systemic Steroids for Acute Respiratory Infections in Korean Outpatient Settings: Overall Patterns and Effects of the Prescription Appropriateness Evaluation Policy
예방의학회지
2020 .01
-
본초 중량비를 이용한 부산대학교 한방병원의 첩약 사용 빈도 분석(2) - 방제 교재 수록 처방을 중심으로 -
대한한의학방제학회지
2015 .01
-
Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence
Infection and Chemotherapy
2020 .01
-
보험급여 한약제제 기준처방 개선방안 설문조사 연구
대한한의학방제학회지
2017 .01
-
Safety and Efficacy of Off-label and Unlicensed Medicines in Children
Journal of Korean Medical Science
2018 .01
-
기존방제를 기반한 처방분석 방법에 관한 연구
대한한의학원전학회지
2021 .11
-
영동지방 의약분업 예외지역 약국들에서의 감기 증상 모의 환자에 대한 약물 처방 현황
보건의료산업학회지
2019 .01
-
Drug Prescription Patterns During Initial Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Study Based on Health Insurance Review and Assessment Database
Journal of Korean Medical Science
2022 .03
이 논문의 저자 정보
최근 본 자료
댓글(0)
0